Barber Daniel 4

What Happened
Daniel Barber, President and CEO of Aquestive Therapeutics (AQST), reported two open-market sales: 4,631 shares on 2026-07-15 at about $4.03 per share for $18,683, and 20,369 shares on 2026-07-16 at about $4.00 per share for $81,509. Combined, Barber sold 25,000 shares for approximately $100,192. These were sales (not purchases), which are often routine liquidity events rather than a company-positive signal.

Key Details

• Transaction dates and reported prices:
  • 2026-07-15: 4,631 shares at ~$4.03, proceeds $18,683 (footnote F1: sales ranged $4.00–$4.04; weighted avg $4.0344).
  • 2026-07-16: 20,369 shares at ~$4.00, proceeds $81,509 (footnote F2: sales ranged $4.00–$4.01; weighted avg $4.00016).
• Total shares sold: 25,000; total reported proceeds: ~$100,192.
• Filing: Form 4 filed 2026-07-17 (covers trades on 7/15–7/16); appears to be within the normal SEC reporting window.
• Shares owned after the transactions: not specified in the provided filing details.
• Footnotes: Reporting person offers to provide, on request, the number of shares sold at each separate price (per F1 and F2).

Context
These were open-market sales (transaction code S). Sales by executives can reflect routine diversification or liquidity needs; they do not by themselves indicate company performance or future guidance. No option exercises, gifts, or 10% owner transactions are reported in the provided data.